Zobrazeno 1 - 10 of 397 pro vyhledávání: '"Bussiere DE"'
1
The mortuary architecture of Jacques Nicolas Bussiere de Pouilly
Jacques Nicolas Bussiere de Pouilly (1804-1875) was perhaps the best-trained and most imaginative architect practicing in mid-nineteenth century New Orleans. In addition to several notable buildings, his legacy includes a sketchbook now owned by the
Zobrazit plný text záznamu
4
Author Correction: Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex.
Autor: Bussiere DE; Novartis Institutes for Biomedical Research, Emeryville, CA, USA. dirksen.bussiere@novartis.com., Xie L; Novartis Institutes for Biomedical Research, Emeryville, CA, USA., Srinivas H; Novartis Institutes for Biomedical Research, Basel, Switzerland., Shu W; Novartis Institutes for Biomedical Research, Emeryville, CA, USA., Burke A; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Be C; Novartis Institutes for Biomedical Research, Basel, Switzerland., Zhao J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Godbole A; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., King D; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Karki RG; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Hornak V; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Xu F; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Cobb J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Carte N; Novartis Institutes for Biomedical Research, Basel, Switzerland., Frank AO; Novartis Institutes for Biomedical Research, Emeryville, CA, USA., Frommlet A; Novartis Institutes for Biomedical Research, Emeryville, CA, USA., Graff P; Novartis Institutes for Biomedical Research, Basel, Switzerland., Knapp M; Novartis Institutes for Biomedical Research, Emeryville, CA, USA., Fazal A; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Okram B; Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA., Jiang S; Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA., Michellys PY; Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA., Beckwith R; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Voshol H; Novartis Institutes for Biomedical Research, Basel, Switzerland., Wiesmann C; Novartis Institutes for Biomedical Research, Basel, Switzerland., Solomon JM; Novartis Institutes for Biomedical Research, Cambridge, MA, USA. jonathan.solomon@novartis.com., Paulk J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA. josh.paulk@novartis.com.
Publikováno v: Nature chemical biology [Nat Chem Biol] 2020 Mar; Vol. 16 (3), pp. 361.
Zobrazit plný text záznamu
5
Akademický článek
Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitors.
Autor: Ramurthy S; HiberCell, Inc., 619 West 54th Street, New York, NY 10019, USA., Pfister KB; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, CA 94608, USA., Boyce RS; Vermont Biosynthetics LLC, 365 Glinnis Road, Northfield, VT 05663, USA., Brown SP; Proneurotech, 161 Oyster Point Blvd., Suite 200, South San Francisco, CA 94080, USA., Costales AQ; Chevron Oronite Company LLC, 100 Chevron Way, Richmond, CA 94801, USA., Desai MC; Gilead Sciences, 333 Lakeside Drive, Foster City, CA 94404, USA., Fang E; Protein Sciences, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, CA 94608, USA., Levine BH; 2026 South Lincoln Avenue, Spokane, WA 99203, USA., Ng SC; 311 Preakness Court, Walnut Creek, CA 94597, USA., Nuss JM; Oppilan Pharma, Ltd., 332 Encinitas Blvd., Encinitas, CA 92024, USA., Ring DB; 2375 Cowper Street, Palo Alto, CA 94301, USA., Shafer CM; Arcus Biosciences, 3928 Point Eden Way, Hayward, CA 94545, USA., Shu W; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, CA 94608, USA., Subramanian S; 3305 Cydonia Ct., Dublin, CA 94568, USA., Wagman AS; Rain Therapeutics Inc., 8000 Jarvis Avenue, Suite 204, Newark, CA 94560, USA., Wang H; Takeda San Diego Inc., 10410 Science Center Dr., San Diego, CA 92121, USA., Bussiere DE; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, CA 94608, USA. Electronic address: dirksen.bussiere@novartis.com.
Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2020 Feb 15; Vol. 30 (4), pp. 126930. Date of Electronic Publication: 2019 Dec 23.
Zobrazit plný text záznamu
6
Akademický článek
A polyomavirus peptide binds to the capsid VP1 pore and has potent antiviral activity against BK and JC polyomaviruses.
Autor: Kane JR; Infectious Diseases, Novartis Institutes for BioMedical Research, Emeryville, United States.; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, United States., Fong S; Infectious Diseases, Novartis Institutes for BioMedical Research, Emeryville, United States., Shaul J; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Emeryville, United States., Frommlet A; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, United States., Frank AO; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, United States., Knapp M; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, United States., Bussiere DE; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, United States., Kim P; Infectious Diseases, Novartis Institutes for BioMedical Research, Emeryville, United States., Ornelas E; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, United States., Cuellar C; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, United States., Hyrina A; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Emeryville, United States., Abend JR; Infectious Diseases, Novartis Institutes for BioMedical Research, Emeryville, United States., Wartchow CA; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, United States.
Publikováno v: ELife [Elife] 2020 Jan 21; Vol. 9. Date of Electronic Publication: 2020 Jan 21.
Zobrazit plný text záznamu
7
Akademický článek
Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex.
Autor: Bussiere DE; Novartis Institutes for Biomedical Research, Emeryville, CA, USA. dirksen.bussiere@novartis.com., Xie L; Novartis Institutes for Biomedical Research, Emeryville, CA, USA., Srinivas H; Novartis Institutes for Biomedical Research, Basel, Switzerland., Shu W; Novartis Institutes for Biomedical Research, Emeryville, CA, USA., Burke A; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Be C; Novartis Institutes for Biomedical Research, Basel, Switzerland., Zhao J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Godbole A; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., King D; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Karki RG; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Hornak V; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Xu F; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Cobb J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Carte N; Novartis Institutes for Biomedical Research, Basel, Switzerland., Frank AO; Novartis Institutes for Biomedical Research, Emeryville, CA, USA., Frommlet A; Novartis Institutes for Biomedical Research, Emeryville, CA, USA., Graff P; Novartis Institutes for Biomedical Research, Basel, Switzerland., Knapp M; Novartis Institutes for Biomedical Research, Emeryville, CA, USA., Fazal A; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Okram B; Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA., Jiang S; Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA., Michellys PY; Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA., Beckwith R; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Voshol H; Novartis Institutes for Biomedical Research, Basel, Switzerland., Wiesmann C; Novartis Institutes for Biomedical Research, Basel, Switzerland., Solomon JM; Novartis Institutes for Biomedical Research, Cambridge, MA, USA. jonathan.solomon@novartis.com., Paulk J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA. josh.paulk@novartis.com.
Publikováno v: Nature chemical biology [Nat Chem Biol] 2020 Jan; Vol. 16 (1), pp. 15-23. Date of Electronic Publication: 2019 Dec 09.
Zobrazit plný text záznamu
8
Akademický článek
Systems Biology of Human Microbiome for the Prediction of Personal Glycaemic Response.
Autor: Kirtipal, Nikhil1, Youngchang Seo1, Jangwon Son2 emd76@catholic.ac.kr, Sunjae Lee1 leesunjae@gist.ac.kr
Publikováno v: Diabetes & Metabolism Journal. Sep2024, Vol. 48 Issue 5, p821-836. 16p.
Zobrazit plný text záznamu
9
Akademický článek
YAP/TAZ interacts with RBM39 to confer resistance against indisulam.
Autor: Ando, Toshinori1 (AUTHOR) toando19@hiroshima-u.ac.jp, Okamoto, Kento2 (AUTHOR), Ueda, Yume2 (AUTHOR), Kataoka, Nanako1 (AUTHOR), Shintani, Tomoaki1 (AUTHOR), Yanamoto, Souichi2 (AUTHOR), Miyauchi, Mutsumi3 (AUTHOR), Kajiya, Mikihito1 (AUTHOR)
Publikováno v: Oncogenesis. 7/15/2024, Vol. 13 Issue 1, p1-8. 8p.
Zobrazit plný text záznamu
10
Akademický článek
Harnessing the anti-cancer natural product nimbolide for targeted protein degradation.
Autor: Spradlin JN; Department of Chemistry, University of California, Berkeley, Berkeley, CA, USA.; Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA., Hu X; Department of Chemistry, University of California, Berkeley, Berkeley, CA, USA.; Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA., Ward CC; Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA., Brittain SM; Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Jones MD; Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Ou L; Department of Chemistry, University of California, Berkeley, Berkeley, CA, USA.; Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA., To M; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA, USA., Proudfoot A; Novartis Institutes for BioMedical Research, Emeryville, CA, USA., Ornelas E; Novartis Institutes for BioMedical Research, Emeryville, CA, USA., Woldegiorgis M; Novartis Institutes for BioMedical Research, Emeryville, CA, USA., Olzmann JA; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA., Bussiere DE; Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA.; Novartis Institutes for BioMedical Research, Emeryville, CA, USA., Thomas JR; Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Vertex Pharmaceuticals, Boston, MA, USA., Tallarico JA; Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., McKenna JM; Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Schirle M; Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Maimone TJ; Department of Chemistry, University of California, Berkeley, Berkeley, CA, USA. maimone@berkeley.edu.; Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA. maimone@berkeley.edu., Nomura DK; Department of Chemistry, University of California, Berkeley, Berkeley, CA, USA. dnomura@berkeley.edu.; Novartis-Berkeley Center for Proteomics and Chemistry Technologies, Berkeley, CA, USA. dnomura@berkeley.edu.; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA. dnomura@berkeley.edu.; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA, USA. dnomura@berkeley.edu.
Publikováno v: Nature chemical biology [Nat Chem Biol] 2019 Jul; Vol. 15 (7), pp. 747-755. Date of Electronic Publication: 2019 Jun 17.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje